Skip to main content
Home

Green Pharmacy

Natural Products Sourcebook

Main menu

  • Home
  • 1000 Superplants
  • Bad News for Big Medicine
  • Pathfinding Naturalists
  • Natural Products Store
  • Slide Viewer
  • Laboratory Medicine

You are here

Home

User login

  • Request new password

Lundbeck updates on clinical phase III study for Lu AF35700 in Treatment-Resistant Schizophrenia - P&T Community

Submitted by Anonymous (not verified) on Thu, 10/25/2018 - 15:23

Lundbeck updates on clinical phase III study for Lu AF35700 in Treatment-Resistant SchizophreniaP&T Communityii Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J; American Psychiatric Association; Steering Committee on Pr

  • Read more about Lundbeck updates on clinical phase III study for Lu AF35700 in Treatment-Resistant Schizophrenia - P&T Community
  • Log in to post comments

Pages

  • « first
  • ‹ previous
  • …
  • 180311
  • 180312
  • 180313
  • 180314
  • 180315
  • 180316
  • 180317
  • 180318
  • 180319
  • …
  • next ›
  • last »
Subscribe to Green Pharmacy RSS
© Janel Hopper Associates